Cargando…
Prognostic impact of CD4-positive T cell subsets in early breast cancer: a study based on the FinHer trial patient population
BACKGROUND: The clinical importance of tumor-infiltrating cluster of differentiation 4 (CD4) T cells is incompletely understood in early breast cancer. We investigated the clinical significance of CD4, forkhead box P3 (FOXP3), and B cell attracting chemokine leukocyte chemoattractant-ligand (C-X-C m...
Autores principales: | Schmidt, Marcus, Weyer-Elberich, Veronika, Hengstler, Jan G., Heimes, Anne-Sophie, Almstedt, Katrin, Gerhold-Ay, Aslihan, Lebrecht, Antje, Battista, Marco J., Hasenburg, Annette, Sahin, Ugur, Kalogeras, Konstantine T., Kellokumpu-Lehtinen, Pirkko-Liisa, Fountzilas, George, Wirtz, Ralph M., Joensuu, Heikki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5827982/ https://www.ncbi.nlm.nih.gov/pubmed/29482642 http://dx.doi.org/10.1186/s13058-018-0942-x |
Ejemplares similares
-
Prognostic Impact of Immunoglobulin Kappa C (IGKC) in Early Breast Cancer
por: Schmidt, Marcus, et al.
Publicado: (2021) -
EndoPredict(®) in early hormone receptor-positive, HER2-negative breast cancer
por: Almstedt, K., et al.
Publicado: (2020) -
ERBB4 Promoter Polymorphism Is Associated with Poor Distant Disease-Free Survival in High-Risk Early Breast Cancer
por: Kurppa, Kari J., et al.
Publicado: (2014) -
Prognostic Significance of Interferon-γ and Its Signaling Pathway in Early Breast Cancer Depends on the Molecular Subtypes
por: Heimes, Anne-Sophie, et al.
Publicado: (2020) -
Prognostic Impact of LAG-3 mRNA Expression in Early Breast Cancer
por: Heimes, Anne-Sophie, et al.
Publicado: (2022)